FDA approves once-daily Idvynso tablet for treating HIV

The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen ...

Cranberry juice may boost UTI antibiotics

More than 400 million people experience a urinary tract infection every year, and some epidemiological studies estimate that more than half of all women will develop at least one in their lifetime. Most UTIs are caused by ...

How disinfectants influence microbes across hospital rooms

Just because a topical antiseptic is swabbed on the skin doesn't mean it stays on the skin. In a new study, Northwestern University scientists studied how a powerful antiseptic, called chlorhexidine, affects bacteria in hospital ...

page 5 from 40